Skip to Content

  • Search

View Additional Section Content

RTOG - 0831 - A Randomized, Double Blinded, Placebo-Controlled Phase III Trial to Evaluate the Effectiveness of a Phosphodiesterase 5 Inhibitor, Tadalafil, in Prevention of Erectile Dysfunction in Patients Treated with Radiotherapy for Prostate Cancer

IRB Protocol Number
NCT00931528, RTOG - 0831

Clinical Trial Categories

  • Prostate Cancer
The Rosenfeld Cancer Center at 215-481-2402


  • The Rosenfeld Cancer Center

Find a Physician
Search Our Directory


Schedule a Test
Request an Appointment


Clinical Trials Details